Bill

Bill > S00036


NY S00036

NY S00036
Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.


summary

Introduced
01/08/2025
In Committee
01/21/2025
Crossed Over
01/22/2025
Passed
02/03/2025
Dead
Signed/Enacted/Adopted
02/03/2025

Introduced Session

2025-2026 General Assembly

Bill Summary

AN ACT to amend the education law, in relation to the labeling of mifepristone, misoprostol, and their generic alternatives

AI Summary

This bill modifies New York State education law to allow prescription labels for medication abortion drugs (specifically mifepristone and misoprostol, and their generic alternatives) to display the name of the health care practice instead of the individual prescriber's name, if the prescriber requests this option. Currently, prescription labels typically require the specific prescriber's name, but this legislation provides flexibility for medication abortion prescriptions, potentially offering increased privacy or administrative convenience for healthcare providers. The bill amends two sections of the education law to explicitly permit this alternative labeling approach, and it will take effect immediately upon becoming law. The change applies specifically to medication abortion drugs, which are commonly used for early pregnancy termination, and gives prescribers the discretion to choose whether they want their individual name or their practice's name on the prescription label.

Committee Categories

Education

Sponsors (6)

Last Action

APPROVAL MEMO.1 (on 02/03/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...